Journals / Anadolu Kardiyoloji Dergisi / 2013 / Cilt: 13 - Sayı: 6

Updates on extracorporeal life support in the world and challenges in Turkey

Yaşam destek sistemlerinin Dünya'daki gelişmeleri ve Türkiye’deki son durum

Pages
580–588
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this paper is to point out this modality, to introduce equipment, and to give information about organization and management to bring this therapeutic option in Turkey in order.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Extracorporeal life support (ECLS) is instituted for the management of life threatening pulmonary or cardiac failure (or both), when no other form of treatment has been or is likely to be successful.
📊
Key Findings & Data:It has being used in developed countries for many years.
💡
Conclusion & Impact:The aim of this paper is to point out this modality, to introduce equipment, and to give information about organization and management to bring this therapeutic option in Turkey in order.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Extracorporeal life support (ECLS) is instituted for the management of life threatening pulmonary or cardiac failure (or both), when no other form of treatment has been or is likely to be successful. It has being used in developed countries for many years. ECLS has come into practice for a while in Turkey, in order to ECLS recommendations. However, most of them are postcardiotomy cases. However, this therapeutic option has more indications including its reason that brought it into practice. All equipment of the system has being changed with the developing technol- ogy. The aim of this paper is to point out this modality, to introduce equipment, and to give information about organization and management to bring this therapeutic option in Turkey in order.

Özet

Ekstrakorporal yaşam desteği (ECLS) medikal tedaviye yanıt vermeyen, yaşamsal fonksiyonların zayıfladığı durumda uygulanan bir tedavi yöntemidir. Gelişmiş ülkelerde uzun yıllardır belli endikasyonlar için kullanılmaktadır. Ülkemizde ise çok yakın bir zamanda, bazı merkezlerde tarif edildiği şekilde kullanılmaya başlanmıştır. Ancak bu kullanımın büyük çoğunluğu postkardiyotomi uygulamalarıdır. Oysa ki bu tedavi şeklinin ortaya çıkış sebebi de dahil olmak üzere dünyadaki uygulama endikasyonları daha geniştir. Gelişen teknoloji ile sistemin hemen tüm ekipmanları değişime uğramaktadır. Bu makaleyi yazmamızdaki amaç, bu ileri tedavi yöntemine dikkat çekmek, ekipmanları tanıtmak, organizasyon ve sistem yönetimi hakkında bilgiler vererek bu tedavinin ülkemize doğru ve etkin şekilde girmesi için önerilerde bulunmaktır.

🔖

Cite This Article

HAYDİN, S., ÜNDAR, A. (2022). Updates on extracorporeal life support in the world and challenges in Turkey. Anadolu Kardiyoloji Dergisi, Cilt: 13 - Sayı: 6, 580–588. https://ajindex.com/articles/436213

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Bartlett RH, Gazzaniga AB, Fong SW, Jefferies MR, Roohk HV, Haiduc N. Extracorporeal membrane oxygenator support for cardiopulmonary failure. Experience in 28 cases. J Thorac Cardiovasc Surg 1977; 73: 375-86
  2. Bartlett RH. 2002 Radvin lecture in basic science. Artificial organs: basic science meets critical care. J Am Coll Surg 2003;196: 171-9. [CrossRef] 3. Wolfson PJ. The development and use of extracorporeal membrane oxygenation in neonates. Ann Thorac Surg 2003; 76: S2224-9. [CrossRef] 4. ELSO GUIDELINES FOR ECMO CENTERS, version 1.7, February 2010, www.elso.med.umich.edu 5. Groom RC, Froebe S, Martin J, Manfra MJ, Cormack JE, Morse C, et al. Update on pediatrics perfusion practice in North America: 2005 survey. J Extra Corpor Technol 2005; 37: 343-50. 6. 4.İstanbul Sempozyumu: Pediyatrik Yaşam Destek Sistemleri ve Pediyatrik Kardiyopulmoner Bypass: 2012’deki En Son Yenilikler, 28.07.2012, İstanbul, Türkiye 7. Guan Y, Su X, McCoach R, Kunselman A, El-Banayosy A, Undar A. Mechanical performance comparison between RotaFlow and CentriMag centrifugal pumps in an adult ECLS model. Perfusion 2010; 25: 71-6. [CrossRef] 8. Zonies D, Bein T, Phillip A, Zimmerman M, Benson C, Fortuna G, Silvey S, (Regensburg) VV-ECMO initiation and transport of NATO combat casualties from a war zone, Presented at the 1st Euro- ELSO Congress; May 11-13, 2012, Rome, Italy 9. Qiu F Talor J, Zahn J, Pauliks L, Kunselmann AR, Palanzo D, et al. Translational Research in Pediatric Extracorporeal Life Support Systems and Cardiopulmonary Bypass Procedures: 2011 Update. World Journal for Pediatric and Congenital Heart Surgery 2011; 2: 476-81. [CrossRef] 10. Vasavada R, Feng Qiu, Undar A. Current status of pediatric/neonatal extracorporeal life support: clinical outcomes, circuit evolution, and translational research. Perfusion 2011; 26: 294-301. [CrossRef] 11. Palanzo D, Qiu F, Baer L, Clark JB, Myers JL, Undar A. Evolution of the Extracorporeal life support circuitry. Artif Organs 2010; 34: 869-73. [CrossRef] 12. Khan S, Vasavada R, Qiu F, Kunselman A, Undar A. Extracorporeal life support systems: alternative vs. conventional circuits. Perfusion 2011: 26: 191-8. [CrossRef] 13. Reed-Thurston D, Shenberger J, Qiu F, Undar A. Neonatal extracorporeal life support: will the newest technology reduce morbidity? Artif Organs 2011; 35: 989-96. [CrossRef] 14. Lorusso R, Gelsomino S, Vizzardi E, De Cicco G, Mastropierro R, Mariotti M, et al. Heparinless ECMO: A Feasible and effective procedure